Literature DB >> 18952583

Stem cells and the origin and propagation of brain tumors.

Brian A Emmenegger1, Robert J Wechsler-Reya.   

Abstract

In recent years there has been a flood of interest in the relationship between brain tumors and stem cells. Some investigators have focused on the sensitivity of normal stem cells to transformation, others have described phenotypic or functional similarities between tumor cells and stem cells, and still others have suggested that tumors contain a subpopulation of ;;cancer stem cells'' that is crucial for tumor maintenance or propagation. Although all these concepts are interesting and provide insight into the origins and properties of brain tumors, the use of similar terms to describe them has led to confusion. The goal of this review is to sort out some of that confusion and highlight what we know and what we have yet to learn.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952583      PMCID: PMC3674560          DOI: 10.1177/0883073808321062

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  70 in total

1.  Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro.

Authors:  Limor Gabay; Sally Lowell; Lee L Rubin; David J Anderson
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

2.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.

Authors:  Anna V Molofsky; Ricardo Pardal; Toshihide Iwashita; In-Kyung Park; Michael F Clarke; Sean J Morrison
Journal:  Nature       Date:  2003-10-22       Impact factor: 49.962

3.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

Authors:  Antonio Cozzio; Emmanuelle Passegué; Paul M Ayton; Holger Karsunky; Michael L Cleary; Irving L Weissman
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

4.  CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells.

Authors:  Cosima V Pfenninger; Teona Roschupkina; Falk Hertwig; Denise Kottwitz; Elisabet Englund; Johan Bengzon; Sten Eirik Jacobsen; Ulrike A Nuber
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

5.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

Authors:  Dagmar Beier; Peter Hau; Martin Proescholdt; Annette Lohmeier; Jörg Wischhusen; Peter J Oefner; Ludwig Aigner; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

7.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

8.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

Authors:  Toru Kondo; Takao Setoguchi; Tetsuya Taga
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

9.  Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells.

Authors:  Ali Jourabchi Ghods; Dwain Irvin; Gentao Liu; Xiangpeng Yuan; Iman R Abdulkadir; Patrizia Tunici; Bindu Konda; Sebastian Wachsmann-Hogiu; Keith L Black; John S Yu
Journal:  Stem Cells       Date:  2007-04-05       Impact factor: 6.277

10.  Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression.

Authors:  Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Federica Locatelli; Dimitra Papadimitriou; Sabrina Salani; Roberto Del Bo; Serena Ghezzi; Sandra Strazzer; Nereo Bresolin; Giacomo P Comi
Journal:  Exp Neurol       Date:  2007-03-28       Impact factor: 5.330

View more
  7 in total

1.  Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.

Authors:  Silvana Valdebenito; Daniela D'Amico; Eliseo Eugenin
Journal:  Cancer Rep (Hoboken)       Date:  2019-11-11

Review 2.  Drosophila melanogaster as a model system for human brain cancers.

Authors:  Renee D Read
Journal:  Glia       Date:  2011-05-02       Impact factor: 7.452

Review 3.  Brain cancer propagating cells: biology, genetics and targeted therapies.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  Trends Mol Med       Date:  2009-11-02       Impact factor: 11.951

4.  Neural stem cells in the adult human brain.

Authors:  Oscar Gonzalez-Perez
Journal:  Biol Biomed Rep       Date:  2012

Review 5.  Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.

Authors:  Monique T Barakat; Eric W Humke; Matthew P Scott
Journal:  Trends Mol Med       Date:  2010-06-16       Impact factor: 11.951

6.  Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

Authors:  Kirti Kandhwal Chahal; Jie Li; Irina Kufareva; Milind Parle; Donald L Durden; Robert J Wechsler-Reya; Clark C Chen; Ruben Abagyan
Journal:  PLoS One       Date:  2019-09-20       Impact factor: 3.240

7.  Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.

Authors:  Pratheesh Sathyan; Pascal O Zinn; Anantha L Marisetty; Bin Liu; Mohamed Mostafa Kamal; Sanjay K Singh; Pierre Bady; Li Lu; Khalida M Wani; Bethany L Veo; Joy Gumin; Dina Hamada Kassem; Frederick Robinson; Connie Weng; Veerabhadran Baladandayuthapani; Dima Suki; Howard Colman; Krishna P Bhat; Erik P Sulman; Ken Aldape; Rivka R Colen; Roel G W Verhaak; Zhimin Lu; Gregory N Fuller; Suyun Huang; Frederick F Lang; Raymond Sawaya; Monika Hegi; Sadhan Majumder
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.